Search NLS News

Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences for up to USD 1.3 billion. “Hypertension is a leading risk factor for cardiovascular events, heart failure, chronic kidney disease and premature death,” says Martin Holst Lange, executive vice president and head of Development at Novo Nordisk. “With its expected benefit-risk profile, […]

AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and granted Priority Review in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). The Prescription Drug User Fee Act date, the FDA action date for their […]

Ultimovacs has announced encouraging overall survival (OS) data from cohort 1 in the UV1-103 Phase I clinical trial in malignant melanoma. Among the patients in cohort 1 who were alive at the 3-year follow-up, no further deaths have been reported, reaffirming an encouraging trend of durable overall survival benefit from UV1 vaccination. “We are very […]

Promotions and hefty raises do not create leaders. While some people always want to sit in the driver’s seat, leadership – effective leadership – is a learned skill.

New Managing Director of Finnish Bioindustries. Finland’s biotechnology industry association Finnish Bioindustries (FIBs) long-term director Carmela Kantor-Aaltonen retired in August 2023 and Alexandra Peth, M.Sc, has been appointed as her successor in a Managing Director role. Congratulations on your new role! What are you most looking forward to? “Thank you! I feel incredibly honored to […]

In two parallel projects, researchers at Karolinska Institutet have been involved in creating the most comprehensive atlases of human brain cells to date. The two studies, which are published in Science, provide clues on different brain diseases and give hope for medical advancements in the future, such as new cancer drugs. You could say that we’ve […]

Zelluna Immunotherapy has announced the appointment of Kenneth LaMontagne as CBO (Chief Business Officer). “I am delighted to have Ken join Zelluna – he brings a rare blend of scientific depth, extensive cell therapy business development expertise spanning pharma and biotech and an impressive deal making track record. Ken is ideally suited to strengthen our […]

Getinge has acquired 100 percent of the shares in US-based Healthmark Industries Co. Inc., a provider of instrument care and infection control consumables, for approximately 320 million USD. This strategic step enhances Getinge’s presence within sterile reprocessing in the US and facilitates a global expansion for Healthmark, it states. “We are excited and honored to […]

The company has announced the decision to stop the once-weekly injectable semaglutide kidney outcomes trial FLOW based on interim analysis. The trial has studied the effect of semaglutide versus placebo on the progression of renal impairment in people with type 2 diabetes and chronic kidney disease. Based on a recommendation from the independent Data Monitoring […]

The Novo Nordisk Foundation (NNF) has awarded eleven new grants through its Research Infrastructure Programme. Scientific progress relies heavily on access to high-quality research infrastructure. The NNF is therefore awarding the new grants for the establishment of world-class research infrastructure supporting innovative research at Danish research institutions. The grants will fund both advanced equipment and […]